Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Expert consensus statement outlines shared medical appointments to improve chronic disease care

The American College of Lifestyle Medicine (ACLM) has published an expert consensus statement identifying best practices for delivering lifestyle interventions through shared medical appointments (SMAs), a care model that combines individualized medical care with group support.

8 Oct 2026

Potassium-rich DASH diet does not cause hyperkalemia in individuals taking blood pressure drugs

Increased consumption of potassium-rich foods that are part of the Dietary Approaches to Stop Hypertension (DASH) diet did not raise blood potassium to dangerous levels in people taking medications to lower their blood pressure, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

8 Oct 2026

Nutritionally similar meals might not affect your body the same way

Ultra-processed foods trigger distinct metabolic and brain responses, influencing insulin release and nutrient processing despite similar nutritional content.

8 Oct 2026

Ancient gut microbes migrated with humans across the globe

As waves of humans left Africa tens of thousands of years ago, eventually populating the entire planet, they were joined on their world-conquering ride by the trillions of microorganisms that compose the gut microbiome.

7 Oct 2026

Metformin in pregnancy does not raise developmental risk in children

Metformin use during pregnancy shows no link to developmental problems at school entry.

7 Oct 2026

High-fiber diet beats metformin for blood sugar and weight in trial

High-fiber diet improves blood sugar and weight more than metformin in a small diabetes trial.

7 Oct 2026

Study links pregnancy complications to future heart and kidney disease

Women with a complication in the latest pregnancy, or in a previous pregnancy, face an elevated risk of developing cardiometabolic-renal conditions in subsequent years, suggests a UK study published online in the open access journal BMJ Medicine.

6 Oct 2026

New global definition changes how childhood obesity is identified

A new global definition of clinical obesity classifies far fewer children as obese than the widely used body mass index (BMI), according to a large international study. And the findings could lead to changes to how childhood obesity is identified and managed.

6 Oct 2026

Ultraprocessed meals produce distinct metabolic and brain responses

Most nutrition science suggests that meals with the same basic nutritional profile will have the same impact on a person's blood sugar.

5 Oct 2026

Long-term "Food Is Medicine" program improves cardiometabolic health in adults

Providing people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension.

5 Oct 2026

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Tirzepatide cuts body fat while preserving skeletal muscle in real-world study

2 Oct 2026

Could the gut be priming the body for a more severe stroke?

Gut bacteria may prime immune cells to worsen stroke damage

2 Oct 2026

Postpartum GLP-1 prescriptions rise sharply among U.S. women

More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.

1 Oct 2026

CBL-514 injection reduces visceral and subcutaneous fat in trials

Details of a new injection that targets fat cells will be released at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2).

1 Oct 2026

Gut bacterial metabolite worsens brain damage after stroke, study finds

Researchers at LMU have discovered how a metabolite produced by gut bacteria can influence brain damage after stroke.

1 Oct 2026

Mauritius becomes first country to reverse type 2 diabetes epidemic

New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that the small island nation of Mauritius is the first country in the world to prove it is reversing the type 2 diabetes epidemic using the objective gold standard testing method of the 2-hour oral glucose tolerance test (2 hour OGTT).

1 Oct 2026

Real-world data reveals higher reported GLP-1 side effects in female patients

The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.

1 Oct 2026

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.

1 Oct 2026

Early-onset type 2 diabetes trial demonstrates significant 24-week fat loss

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Regional Health Americas journal shows that in people who have developed early onset type 2 diabetes (EOT2D) (aged under 45 years), around half these T2D cases can be reversed with a low-energy diet combined with a structured exercise program.

1 Oct 2026

Study examines the real-world use of GLP-1 RA drugs in children and young people

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has examined the real-world use of GLP-1 receptor agonist (GLP-1 RA) drugs in children and young people in Germany, Austria and Luxembourg.

30 Sep 2026